Flamel Technologies (FLML) Files SPA with FDA for Pivotal Micropump Phase 3
Tweet Send to a Friend
Flamel Technologies (Nasdaq: FLML) announced that it has filed a Special Protocol Assessment (SPA) with the U.S. Food and Drug ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE